Delivery Order SPE2DB24D2205-SPE2DB24FDZWN
Award Date
9/12/24
Potential Completion Date
9/13/24
Potential Value
$3.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) to supply BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the U.S. federal government. The contract has a ceiling value of $4,269.30 and a completion date of June 10, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
This is a delivery order (contract) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of BOOSTRIX TDAP vaccine syringes. The contract has a ceiling value of $66,998.32 and a performance period through August 27, 2024. This contract is not designated as a set-aside. Amerisourcebergen has been awarded numerous federal contracts by various defense and civilian agencies to provide a wide range of pharmaceutical...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a vaccine product, with a ceiling value of $1,021.72 and a period of performance through September 16, 2024. This order is not subject to a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract has a ceiling value of $63,270.00 and an ultimate completion date of August 28, 2024. The contract is a firm-fixed-price type and does not have a set-aside designation. AmerisourceBergen, as a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of medical supplies,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, with a ceiling value of $10,720.50 and a performance period extending through June 4, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The firm-fixed-price contract, valued at $1,518.48, has an ultimate completion date of August 19, 2024. This award is not associated with a set-aside program. As a leading supplier of pharmaceutical products and medical supplies to the U.S. federal government, Amerisourcebergen leverages its extensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, with a ceiling value of $1,330.50 and a period of performance ending on May 8, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a pharmaceutical product, with a ceiling value of $6,120.30. The contract is a firm fixed-price, non-set-aside delivery order with a performance period ending on May 13, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $20,246.40 firm-fixed-price contract is for the supply of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML product, with a completion date of August 14, 2024. Amerisourcebergen is a leading pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of medical commodities, including medications, vaccines, and medical supplies, to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division for the provision of BOOSTRIX TDAP vaccine syringes. The contract has a firm fixed price of $12,147.84 and will run through September 25, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999, for the supply of a wide range of medical...